A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

AIDS. 2022 Feb 1;36(2):319-321. doi: 10.1097/QAD.0000000000003114.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • HIV Infections* / complications
  • Humans
  • Immunity
  • Yellow Fever Vaccine*
  • Yellow Fever* / prevention & control

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Yellow Fever Vaccine